Our Main Focus of Work
“To Make a difference to life of transfusion dependent thalassemic children”
ERADICATION OF THALASSEMIA BY TREATMENT AND PREVENTION:
Bone Marrow Transplant: This is the only curative treatment for beta thalassemia currently. Advances in conditioning regimens have now allowed higher risk patients to be successfully transplanted by allogeneic transplant from matched related donor.
- Population Screening: It is estimated that about 8-12% population carries thalassemia gene with no symptoms of the disease. This requires screening of population at large to detect the carriers by simple method of blood testing. Once identified, the carriers are counseled about the disease and how they can help prevent the disease.
- Detection – Prenatal diagnosis by DNA based method using chorionic villi sampling. This specialized test is done in 10-12 weeks of pregnancy, as there are 25% chances of foetus being affected if both parents are carrier / thalassemia minor.